Elevation Oncology, Inc.: debt financing — Elevation Oncology prepays $32.3M term loan, discharges all obligations

Elevation Oncology, Inc.

Voluntary prepayment of $32.3M aggregate principal, interest, fees and expenses on May 2, 2025.
Original principal $30M; prepayment fee $300K; final payment $1.935M plus accrued interest and expenses.
Prepayment satisfied and discharged all obligations under Loan Agreement from July 2022 (as amended March 2024).
All security interests and liens on company assets released and discharged.

item 2.04

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Elevation Oncology, Inc. faced acceleration on term loan of $30,000,000 with Lenders.

Instrument: term loan
Principal: $30,000,000
Counterparty: Lenders
Event: acceleration

Exact text from the filing

K2 HealthVentures LLC, as administrative agent, and Ankura Trust Company, LLC, as collateral agent. The payoff amount reflects the aggregate original principal amount of $30,000,000, a prepayment fee of $300,000, a final payment in the amount of $1,935,000, accrued interest and Lenders’ expenses. As provided in the Payoff Letter between the Lenders and the

View on SEC.gov

Browse all debt financings →

Source: SEC EDGAR

accession 0001558370-25-006298

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.